Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake |
Read More
diabetes
We’re raising our Eli Lilly price target — what a difference a quarter makes
Eli Lilly shares jumped Thursday after the drugmaker posted a strong third quarter, driven by sales of its popular GLP-1
Read More
Eli Lilly pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.
Read More
Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients; shares
Eli Lilly on Thursday said its daily obesity pill met the company’s goals in the first of several late-stage trials,
Read More